智通财经APP获悉，上美股份(02145)盘中涨超6%，截至发稿，涨3.27%，报37.9港元，成交额1552.3万 港元。 消息面上，据蝉妈妈数据显示，1月，上美股份旗下品牌韩束总GMV达7.73亿元，位列抖音美妆排名榜 首，取得断层式领先。据悉，该成绩不仅是欧莱雅的近4倍，更创下韩束单月抖音GMV新高、抖音美妆 行业单月GMV新纪录。 此外，值得一提的是，韩束限定红蛮腰礼盒一经上线即在各平台热销。数据显示，新年限定红蛮腰礼盒 上线仅15天，就已实现了35.8万套的全渠道销量，且在1月13日-28日春节特别策划期间，韩束成交GMV 累计超过4.3亿元。 ...

Shanghai Chicmax Cosmetic Co., Ltd. 上海上美化妝品股份有限公司 Interim Report 2023 中期報告 （於中華人民共和國註冊成立的股份有限公司） 股份代號 : 2145 2023 中期報告 | --- | --- | --- | --- | --- | --- | --- | |--------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 目錄 | | | | | | | | | | | | | | | | | | | | | | | | 公司資料 | | | | | | | | | | 2 | | | | | | 業務回顧及展望 | | 4 | | | | | | | | | | | | | | 財務概要 | | 11 | | | | | | | | | | | | | | 管理 ...

Revenue and Profit Growth - Revenue increased by 25.7% to RMB 1,586.8 million in the first half of 2023 compared to RMB 1,262.4 million in the same period of 2022[2] - Gross profit rose by 33.7% to RMB 1,095.5 million in the first half of 2023 from RMB 819.5 million in the first half of 2022[2] - Net profit surged by 60.7% to RMB 100.9 million in the first half of 2023 compared to RMB 62.8 million in the same period of 2022[2] - Revenue increased by 25.7% from RMB 1,262.4 million in H1 2022 to RMB 1,586.8 million in H1 2023, driven by growth in emerging e-commerce platforms like Douyin[21] - Gross profit increased by 33.7% from RMB 819.5 million in H1 2022 to RMB 1,095.5 million in H1 2023, with gross margin improving from 64.9% to 69.0%[27] - Profit for the first half of 2023 was RMB 100.9 million, compared to RMB 62.8 million in the first half of 2022[34] - Revenue for the first half of 2023 was RMB 1,586.8 million, up from RMB 1,262.4 million in the first half of 2022, with gross profit increasing to RMB 1,095.5 million from RMB 819.5 million[38] - Total revenue for the six months ended June 30, 2023, was RMB 1,586,826 thousand, an increase from RMB 1,262,394 thousand in the same period in 2022[45][47][48][49] - Basic earnings per share for the six months ended June 30, 2023, were RMB 0.25, up from RMB 0.18 for the same period in 2022[54] Brand Performance - HanShu brand revenue grew by 70.3% to RMB 1,028.0 million in the first half of 2023, accounting for 64.8% of total revenue[7] - One Leaf brand revenue decreased by 23.1% to RMB 203.6 million in the first half of 2023, representing 12.8% of total revenue[9] - Red Elephant's revenue in the first half of 2023 was RMB 189.1 million, a decrease of 38.2% compared to the same period in 2022, accounting for 11.9% of the company's total revenue[10] - Newpage's revenue in the first half of 2023 was RMB 59.0 million, a significant increase of 209.1 times compared to the same period in 2022, contributing 3.7% of the company's total revenue[11] - The company's total revenue from its three main brands in the first half of 2023 was RMB 1,420.7 million, an increase of 21.0% year-on-year, accounting for 89.5% of total revenue[10] - HanShu brand revenue grew from RMB 603.6 million in H1 2022 to RMB 1,028.0 million in H1 2023, accounting for 64.8% of total revenue[22][23] - Skincare category revenue rose from RMB 929.7 million in H1 2022 to RMB 1,282.9 million in H1 2023, driven by HanShu[26] Product Launches and Innovations - HanShu launched new product lines including "White Waist Series" and "Blue Waist Series" in the first half of 2023[7] - One Leaf introduced a new product, the Light Repair Water Essence, featuring 10% panthenol and olive leaf extract in the first half of 2023[8] - The company launched new products such as the "Soothing Special Care Essence" and "Chardonnay Grape Essence Cream" under the Red Elephant brand in the first half of 2023[10] - Newpage introduced the "Baby Soothing Special Care Essence Lotion" in the first half of 2023, featuring natural organic bisabolol and glycyrrhetinic acid for skin barrier strengthening[11] Marketing and Distribution - Online channel revenue increased to RMB 1,291.2 million in H1 2023, representing 81.4% of total revenue, up from 73.8% in H1 2022[24] - Online self-operated sales revenue surged from RMB 485.7 million in H1 2022 to RMB 983.8 million in H1 2023, primarily due to Douyin[25] - Sales and distribution expenses increased by RMB 242.7 million to RMB 850.6 million in H1 2023, accounting for 53.6% of revenue, up from 48.2% in H1 2022[29] - Marketing and promotion expenses rose by RMB 220.0 million to RMB 629.7 million in H1 2023, reflecting increased brand exposure and channel investment[29] - Marketing and promotion expenses increased significantly to RMB 630,208 thousand in 2023, compared to RMB 407,633 thousand in 2022[51] R&D and Innovation - R&D expenditure in the first half of 2023 was RMB 54.4 million, accounting for 3.4% of total revenue, compared to RMB 51.9 million (4.1% of total revenue) in the same period in 2022[14] - The company applied for 40 new patents in the first half of 2023, including 24 invention patents, and was granted 7 new patents, including 2 invention patents[14] - The company plans to strengthen its R&D focus on anti-aging and skin barrier repair technologies to drive product innovation[19] - R&D costs rose by 4.8% from RMB 51.9 million in the first half of 2022 to RMB 54.4 million in the first half of 2023, driven by increased R&D activities[31] - 12.2% of the net proceeds (HKD 104.9 million) were allocated to enhance R&D capabilities, with HKD 24.8 million used and HKD 80.1 million remaining[65] Financial Position and Capital Expenditure - Capital expenditure in the first half of 2023 was RMB 35.6 million, primarily for new machinery, equipment, vehicles, factory expansion, and construction payments[16] - The company's right-of-use assets as of June 30, 2023, were RMB 135.1 million, with lease liabilities of RMB 70.0 million[17] - Total payroll costs in the first half of 2023 were RMB 238.4 million, an increase from RMB 217.5 million in the same period in 2022[15] - Cash and cash equivalents stood at RMB 581.0 million as of June 30, 2023, down from RMB 1,147.7 million as of December 31, 2022, while external bank borrowings decreased by 60.1% to RMB 259.4 million[34] - The company's debt-to-asset ratio improved to 38.4% as of June 30, 2023, from 61.6% in the same period last year, and the current ratio increased to 1.8x from 1.1x[35] - The company's cash and bank balances were predominantly denominated in RMB (97.2%) as of June 30, 2023, compared to 28.5% as of December 31, 2022, reflecting a shift in currency exposure[37] - Total assets as of June 30, 2023, were RMB 1,996,060 thousand, up from RMB 1,893,501 thousand as of December 31, 2022[41] - Total liabilities decreased to RMB 1,082,608 thousand as of June 30, 2023, from RMB 1,439,022 thousand as of December 31, 2022[41][42] - Net current assets stood at RMB 803,290 thousand as of June 30, 2023, down from RMB 938,436 thousand as of December 31, 2022[41] - The company's equity attributable to owners of the parent company increased to RMB 1,726,917 thousand as of June 30, 2023, from RMB 1,705,086 thousand as of December 31, 2022[42] - The company's investment in associates increased significantly to RMB 16,264 thousand as of June 30, 2023, from RMB 1,797 thousand as of December 31, 2022[41] - Inventory as of June 30, 2023, was RMB 472,456 thousand, down from RMB 518,113 thousand as of December 31, 2022[56] - Trade receivables and bills receivable net of impairment were RMB 289,895 thousand as of June 30, 2023, compared to RMB 373,985 thousand as of December 31, 2022[57] - Trade payables as of June 30, 2023, were RMB 359,446 thousand, down from RMB 424,150 thousand as of December 31, 2022[60] Dividends and Shareholder Returns - The company proposed an interim dividend of RMB 0.2 per share for the first half of 2023, subject to shareholder approval[2] - The company declared an interim dividend of RMB 0.20 per ordinary share for the six months ended June 30, 2023, totaling approximately RMB 79,591,580[55] - The board has proposed an interim dividend of RMB 0.2 per share for the first half of 2023, subject to approval at the extraordinary general meeting on October 16, 2023[69] Regulatory and Corporate Governance - The company plans to revise its articles of association in accordance with recent regulatory changes, with the proposed amendments to be voted on at the extraordinary general meeting on October 16, 2023[70] Other Income and Expenses - Other income and gains increased by 13.2% from RMB 59.3 million in H1 2022 to RMB 67.1 million in H1 2023, mainly due to foreign exchange and financial asset gains[28] - Administrative expenses increased by 9.1% from RMB 102.6 million in the first half of 2022 to RMB 111.9 million in the first half of 2023, primarily due to employee benefits and office-related costs[30] - Net impairment loss on financial assets reversed from a loss of RMB 0.7 million in the first half of 2022 to a recovery of RMB 14.7 million in the first half of 2023, mainly due to reduced expected credit losses on trade receivables[31] - Other expenses decreased by 20.7% from RMB 27.1 million in the first half of 2022 to RMB 21.5 million in the first half of 2023, primarily due to reduced inventory impairment losses and no foreign exchange losses[32] - Finance costs increased by 19.4% from RMB 9.8 million in the first half of 2022 to RMB 11.7 million in the first half of 2023, mainly due to higher interest on bank and other borrowings[33] - Total tax expense for the six months ended June 30, 2023, was RMB 23,481 thousand, compared to RMB 15,586 thousand for the same period in 2022[53] Capital Market Activities - The company's H shares were listed on the Hong Kong Stock Exchange on December 22, 2022, with net proceeds from the global offering amounting to approximately HKD 859.7 million[64] - The total net proceeds from the global offering amounted to approximately HKD 859.7 million, including HKD 835.1 million from the December 2022 global offering and HKD 24.6 million from the partial exercise of the over-allotment option in January 2023[66] - As of June 30, 2023, the company has utilized HKD 335.7 million of the net proceeds, with HKD 524.0 million remaining, expected to be fully utilized by December 31, 2026[65] - The company allocated 32.0% of the net proceeds (HKD 275.5 million) for brand-building activities, with HKD 69.9 million already used and HKD 205.6 million remaining[65] - 19.8% of the net proceeds (HKD 170.6 million) were allocated to strengthen production and supply chain capabilities, with only HKD 1.4 million used and HKD 169.2 million remaining[65] - The company allocated 18.0% of the net proceeds (HKD 154.5 million) to expand its sales network, with the entire amount already utilized[65] Brand Experience and Collaborations - HanShu established its first "Scientific Anti-Aging" brand experience center at Shanghai Hongqiao Airport in the first half of 2023[7] - One Leaf collaborated with TMall Innovation Center and Kantar to release China's first "Clean Beauty Industry White Paper" in the first half of 2023[8]

Financial Performance - Revenue decreased from RMB 3,618.9 million in 2021 to RMB 2,675.3 million in 2022, representing a decline of approximately 26.1%[6] - Gross profit fell from RMB 2,360.6 million in 2021 to RMB 1,699.6 million in 2022, a decrease of about 28.0%[6] - Net profit for 2022 was RMB 137.1 million, down from RMB 338.8 million in 2021, indicating a decline of approximately 59.6%[6] - Skincare revenue decreased by 27.4% from RMB 2,679.7 million in 2021 to RMB 1,944.8 million in 2022, while maternal and infant care revenue decreased by 21.6% from RMB 901.9 million to RMB 706.7 million[23] - The company's total comprehensive income for the year was RMB 330,623,000, down from RMB 338,771,000 in the previous year, reflecting a decrease of about 2%[178] - The company's operating cash flow for 2022 was RMB 36,561,000, a significant decrease from RMB 335,193,000 in 2021, reflecting a decline of approximately 89%[180] Dividend and Shareholder Returns - The board proposed a final dividend of RMB 0.25 per share for the year ended December 31, 2022, compared to RMB 0.56 per share for the previous year[6] - The proposed final dividend for the year ended December 31, 2022, is RMB 0.25 per share, compared to approximately RMB 0.56 per share in 2021[112] Brand Strategy and Market Position - The company focuses on a multi-brand strategy, successfully launching several cosmetic brands including Han Shu, Yi Ye Zi, and Hong Se Xiao Xiang to meet diverse consumer needs[7][8] - The company aims to consolidate its three main brand core positions to drive overall performance growth[8] - The company continues to leverage its multi-brand strategy to seize market opportunities and differentiate itself from competitors[7] Revenue Breakdown by Brand - Han Shu generated revenue of RMB 1,267.4 million in 2022, a decrease of 22.3% compared to 2021, accounting for 47.4% of total annual revenue[9] - Yi Ye Zi's revenue in 2022 was RMB 529.9 million, down 36.2% from 2021, representing 19.8% of total annual revenue[9] - Hong Se Xiao Xiang's revenue for 2022 was RMB 655.1 million, a decrease of 24.8% year-over-year, contributing 24.5% to total annual revenue[11] - Total revenue from the three main brands in 2022 was RMB 2,452.4 million, reflecting a decline of 26.4% from 2021, and accounting for 91.7% of total revenue[11] Research and Development - Research and development expenses for 2022 were RMB 110.3 million, representing 4.1% of total revenue, compared to RMB 104.7 million and 2.9% in 2021[14] - New product launches in 2022 included the TIRACLE PRO and blue copper peptide series, which received multiple awards for innovation[9] - Yi Ye Zi is being repositioned to focus on natural plant-based skincare, with a new product line featuring Gansu olive leaf extract[10] - The company plans to enhance its R&D activities in plant extraction technology and skin barrier repair for Yi Ye Zi[10] Financial Position and Assets - The total assets increased from RMB 2,274.6 million in 2021 to RMB 3,145.7 million in 2022[17] - As of December 31, 2022, cash and cash equivalents amounted to RMB 1,147.7 million, up from RMB 145.2 million in 2021[31] - The debt-to-equity ratio increased from 29.9% in 2021 to 42.7% in 2022, indicating a higher leverage position[32] Corporate Governance - The board consists of a balanced mix of executive and non-executive directors, ensuring independent judgment[52] - The company has established appropriate liability insurance for directors and senior management, which is reviewed annually[57] - The board is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance corporate value[50] - The company has confirmed that all directors complied with the trading standards during the relevant period[51] Risk Management - Major risks identified include business risks, financial risks, compliance risks, insider information risks, and internal control risks[80] - The company has established a risk management framework to identify and control significant risks, ensuring business objectives are met and compliance with regulations is maintained[81] Employee and Management Structure - The total number of full-time employees as of December 31, 2022, is 2,572, with 2,505 located in mainland China and 67 in Japan[35] - The company has achieved a gender diversity ratio of 84.91% female employees (2,184) and 15.09% male employees (388) across the organization[75] Audit and Compliance - The audit opinion confirms that the consolidated financial statements present a true and fair view of the group's financial position as of December 31, 2022[164] - The independent auditor confirmed that there were no findings indicating that disclosed continuing connected transactions were not approved by the board[131] Shareholder Communication - The company is committed to effective communication with shareholders, particularly through annual general meetings and other shareholder meetings[91] - The company encourages shareholder participation in annual general meetings and provides various communication channels for shareholder inquiries[95] Future Plans and Utilization of Proceeds - 32% of the net proceeds, approximately HKD 275.5 million, is allocated for brand building activities to enhance brand recognition and establish new brand images, expected to be fully utilized by the end of 2026[100] - The company plans to gradually utilize the net proceeds based on current market conditions and business needs, with adjustments as necessary[102]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 Shanghai Chicmax Cosmetic Co., Ltd. 上海上美化妝品股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2145） 截至2022年12月31日止年度全年業績公告 上海上美化妝品股份有限公司（「本公司」）董事（「董事」）會（「董事會」）公佈本公 司及其附屬公司（統稱「本集團」）截至2022年12月31日止年度（「報告期」）的綜合 年度業績，連同截至2021年12月31日止年度的比較數字。除本公告另有界定者 外，本公告所用詞彙與本公司日期為2022年12月12日的招股章程（「招股章程」） 所界定者具有相同涵義。 表現摘要 | --- | --- | --- | --- | |----------|----------------------|----------------------------------------|--------------| | ...